Neuroblastomas, the most prevalent malignant solid neoplasms of childhood, originate from progenitor cells of the sympathetic nervous system. Their genetic causation is diverse and involves multiple molecular mechanisms. This review highlights multiple roles of microRNA in neuroblastoma pathogenesis and discusses the prospects of harnessing these important natural regulator molecules as biomarkers, therapeutic targets and pharmaceuticals in neuroblastoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11033-022-08137-y | DOI Listing |
Publication Analysis
Top Keywords
biomarkers therapeutic
8
therapeutic targets
8
targets pharmaceuticals
8
pharmaceuticals neuroblastoma
8
micrornas prospective
4
prospective biomarkers
4
neuroblastoma neuroblastomas
4
neuroblastomas prevalent
4
prevalent malignant
4
malignant solid
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!